SEARCH
A great gift
for crisis deniers!
Humoring the Horror of the
Converging Emergencies
94 color pages
$24.99 now $15!
Or read FREE online!
Twitter
Ping this story
in social media:
del.icio.us
Digg
Newsvine
NowPublic
Reddit
Facebook
StumbleUpon
|
 |
|
 |
|
 |
|
 |
|
Despite superbug crisis, progress in antibiotic development 'alarmingly elusive' http://apocadocs.com/s.pl?1366285410
Despite the desperate need for new antibiotics to combat increasingly deadly resistant bacteria, the U.S. Food and Drug Administration (FDA) has approved only one new systemic antibiotic since the Infectious Diseases Society of America (IDSA) launched its 10 x '20 Initiative in 2010 -- and that drug was approved two and a half years ago.
In a new report, published online today in Clinical Infectious Diseases, IDSA identified only seven new drugs in development for the treatment of infections caused by multidrug-resistant gram-negative bacilli (GNB) bacteria. GNB, which include the "nightmare bacteria" to which the Centers for Disease Control and Prevention (CDC) alerted the public in its March 2013 Vital Signs report, represent the most pressing medical need. Importantly, there is no guarantee that any of the drugs currently in development to treat GNB will make it across the finish line to FDA approval and none of them will work against the most resistant bugs we're worried about today.
|
|
 |
|
 |
|
 |
[Read more stories about:
antibiotic resistance, superbugs]
This item will appear in our PANIQuiz!
|
 |
|
New!:
| |
|
No reader quips yet -- be the first! | |
|
Got a PaniQuip?
|
|
|
We reserve the
right to reuse, remove, or refuse any entry.
| |
|
|
'Doc Michael says:
|
|
|
 |
There are alternatives.
|
|
|
|
|
Want to explore more?
Try the PaniCloud!
|
